Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium cloth for Palmar Hyperhidrosis
NCT03880266Phase 2Completed
- Sponsor
- Journey Medical Corporation
- Start
- Feb 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glycopyrronium in palmar hyperhidrosis (PH) (8 arms), sponsored by Journey Medical Corporation. Primary endpoint: Hand Sweating Severity Score at 2 weeks. Started Feb 2019; status: completed.
02
Drugs
glycopyrronium
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT03880266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03880266.